[Quantitative amino acid makeup and the characteristics of the amino groups of ristomycin and the products of its partial acid hydrolysis]. 1978

G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina

The quantitative amino acid composition of ristomycin A, a glycopeptide antibiotic, peptides I-IV (from partial acid hydrolysis of the antibiotic) and their dinitrophenylic derivatives was determined. It was shown that both ristomycin and free peptides I-IV contained one residue of ristomycinic acid and one residue of actinoidinic acid, diamino-dicarbonic amino acids of the glycylphenolic type. Peptides I-IV had close molecular weights, i.e. 1100-1200 and differed from each other in the gradually increasing numbers of NH2- and COON- groups, from one in peptide I to four in peptide IV. The quantitative amino acid analysis of the dinitrophenylic derivatives of ristomycin and peptides I-IV showed that the free NH2-group in peptide I belonged to ristomycinic acid, the same as in the antibiotic, while in peptides III-IV at least one of the free NH2-groups belonged to ristomycinic acid and the other belonged to actinoidinic acid.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D004140 Dinitrophenols Organic compounds that contain two nitro groups attached to a phenol.
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin

Related Publications

G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
October 1972, Antibiotiki,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
January 1978, Mikrobiologiia,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
January 1980, Voprosy pitaniia,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
January 1980, Veterinarno-meditsinski nauki,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
August 1968, Antibiotiki,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
January 1975, Biokhimiia (Moscow, Russia),
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
August 1986, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
January 1977, Cold Spring Harbor symposia on quantitative biology,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
April 1979, Antibiotiki,
G S Katrukha, and A B Silaev, and Zh P Trifonova, and B Diarra, and N N Lomakina
January 1973, Voprosy pitaniia,
Copied contents to your clipboard!